Risks of testosterone-replacement therapy and recommendations for monitoring.
about
Testosterone for the aging male; current evidence and recommended practiceThe benefits and risks of testosterone replacement therapy: a reviewTestosterone treatment comes of age: new options for hypogonadal menTestosterone replacement therapy in patients with prostate cancer after radical prostatectomyTestosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practicesAdvances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapyTransversal European survey on testosterone deficiency diagnosis.Male hypogonadism. Part I: Epidemiology of hypogonadism.Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS).Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.Development of focal segmental glomerulosclerosis after anabolic steroid abuseHormone replacement therapy and physical function in healthy older men. Time to talk hormones?Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging.Effect of Phaleria macrocarpa on sexual function of rats.Off-label use of hormones as an antiaging strategy: a reviewAndrogen insufficiency in ageing men: how is it defined and should it be treated?The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.Optimal management of sarcopenia.A practical guide to male hypogonadism in the primary care setting.Prenatal virilization associated with paternal testosterone gel therapy.Clinical applications of centrally acting agents in male sexual dysfunction.The association of time of day and serum testosterone concentration in a large screening population.How I treat late effects in adults after allogeneic stem cell transplantation.The male biological clock is ticking: a review of the literature.Men's health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approach.Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010.Aging and exercise training reduce testes microvascular PO2 and alter vasoconstrictor responsiveness in testicular arterioles.Not so benign haematology: anaemia of the elderlyTestosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.Risks of testosterone replacement therapy in ageing men.Pharmacotherapy of osteoporosis in men.Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.Clinical experiences with testosterone therapy: prostate safety.Interaction between bone and muscle in older persons with mobility limitationsMultiple Intussusceptions Associated with Polycythemia in an Anabolic Steroid Abuser, A Case Report and Literature ReviewThe effects of opioids on the endocrine system: an overview.Androgen deficiency and hormone-replacement therapy.Osteoporosis and hypogonadism in men.Bone Micro-CT Assessments in an Orchidectomised Rat Model Supplemented with Eurycoma longifolia.
P2860
Q24647679-16251A83-E8F3-4EC0-89A6-2C25E62AA761Q24658011-55F1F3CA-E6AA-4AA4-9D18-77999D232095Q28258718-7137A334-FB70-435C-BB1A-0EB0E0FE0469Q28285210-FA70D8B9-B04D-4C25-BB2B-226C1B625723Q28295533-EE0169BE-6313-4C3B-AD07-C20869D276FCQ28829239-BCD16806-6CEE-4608-85F8-ADEF9E3CC74BQ30318156-9144722C-39E5-49F1-887C-20302308B16AQ30351499-EBB4FBAD-19B8-4FA8-AE6D-40B29ADBED2DQ30597556-8B1F4EE9-4584-48C5-A463-70CDBCF80301Q33276072-664A7F55-92BB-4ECC-B474-CB98F4091FCCQ33562274-4F3E4C01-19E4-4FC9-866C-69BB98E0D244Q33569163-6B8078BB-3EBE-4640-82A5-8BCE41B5F82DQ33764496-C3DA60DA-B94F-412E-852F-947C17A25A00Q33823604-B26065B1-3051-4E73-A496-B42F1909CDB8Q33976165-93E09C19-5A16-4139-AFAC-62219DCCA729Q34055873-DF759150-5402-44A2-BE9A-434B38796ABBQ34097510-9787A81C-4378-4F09-93F7-FBB2A0EBE978Q34121822-6C44C765-7B72-44AD-8B36-C1DF3E0FA4B3Q34167760-F5720A7B-1093-4B54-9555-E86E4110CC25Q34189669-F328FB79-0E22-432F-A0E1-749BFB178972Q34593179-8FBC6AEA-3AE5-430B-9F88-572995E84630Q34635438-101C7996-173A-4B1A-9B9B-E5B20561078FQ34707208-01AC3932-6578-417B-BE9B-24CF59567691Q34810371-3EB33773-69B4-40EE-861E-7E25A61C98DAQ34884322-3724142B-B92B-47BA-B3D6-5C6511F5FC47Q35044878-E6AD0BFB-9B58-40A7-AFA4-F0DF4E82CE08Q35217432-9C153E21-C5E4-423E-A87F-FC5F1FC02D18Q35631773-71D1892F-0E80-45AF-B489-8EE6AE3BCCE5Q35810322-5057AD33-8712-4C8B-8242-2691917BE70CQ35852422-385D4021-61B5-4CC5-B22A-74C5B4D8F5AAQ35925655-44BDBEA9-F858-45CF-A230-AA6DD22826D8Q36040673-F52264F3-CAB2-466F-9908-57668E6853C4Q36065521-A8295CDA-A80F-443A-A3D6-979D2B55E3BDQ36084044-EC3F861A-01D1-44EC-8A2D-D6BCCE6D15B8Q36100758-8F9C0BCC-898F-4E8E-AD41-0FB623A3F61CQ36124454-DFCB2904-3C26-400C-8A7B-9DFA3C84DCBFQ36137885-A8E95D9E-BAD7-46D6-94DC-70950A0E875AQ36185648-78B902D4-7CB5-45F1-BDD2-0D0F1A22E7D9Q36198375-4DACBCD2-07DB-4A08-A0B1-99D7CD8551BDQ36200233-9D533F16-09D0-47A0-AB16-8C0142918DD8
P2860
Risks of testosterone-replacement therapy and recommendations for monitoring.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Risks of testosterone-replacement therapy and recommendations for monitoring.
@ast
Risks of testosterone-replacement therapy and recommendations for monitoring.
@en
type
label
Risks of testosterone-replacement therapy and recommendations for monitoring.
@ast
Risks of testosterone-replacement therapy and recommendations for monitoring.
@en
prefLabel
Risks of testosterone-replacement therapy and recommendations for monitoring.
@ast
Risks of testosterone-replacement therapy and recommendations for monitoring.
@en
P356
P1476
Risks of testosterone-replacement therapy and recommendations for monitoring.
@en
P2093
Abraham Morgentaler
Ernani Luis Rhoden
P304
P356
10.1056/NEJMRA022251
P407
P577
2004-01-01T00:00:00Z